176 related articles for article (PubMed ID: 29349527)
1. Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress.
Stump TK; Aspinwall LG; Kohlmann W; Champine M; Hauglid J; Wu YP; Scott E; Cassidy P; Leachman SA
J Genet Couns; 2018 Aug; 27(4):955-967. PubMed ID: 29349527
[TBL] [Abstract][Full Text] [Related]
2. Priority of Risk (But Not Perceived Magnitude of Risk) Predicts Improved Sun-Protection Behavior Following Genetic Counseling for Familial Melanoma.
Taber JM; Aspinwall LG; Drummond DM; Stump TK; Kohlmann W; Champine M; Cassidy P; Leachman SA
Ann Behav Med; 2021 Feb; 55(1):24-40. PubMed ID: 32415830
[TBL] [Abstract][Full Text] [Related]
3. Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.
Aspinwall LG; Stump TK; Taber JM; Drummond DM; Kohlmann W; Champine M; Leachman SA
Transl Behav Med; 2018 Jan; 8(1):29-43. PubMed ID: 29385581
[TBL] [Abstract][Full Text] [Related]
4. Parental preferences for CDKN2A/p16 testing of minors.
Taber JM; Aspinwall LG; Kohlmann W; Dow R; Leachman SA
Genet Med; 2010 Dec; 12(12):823-38. PubMed ID: 21045708
[TBL] [Abstract][Full Text] [Related]
5. Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.
Aspinwall LG; Taber JM; Kohlmann W; Leaf SL; Leachman SA
Genet Med; 2014 Nov; 16(11):846-53. PubMed ID: 24763292
[TBL] [Abstract][Full Text] [Related]
6. Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.
Aspinwall LG; Taber JM; Leaf SL; Kohlmann W; Leachman SA
Psychooncology; 2013 Feb; 22(2):276-89. PubMed ID: 23382133
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A testing and genetic counseling promote reductions in objectively measured sun exposure one year later.
Stump TK; Aspinwall LG; Drummond DM; Taber JM; Kohlmann W; Champine M; Cassidy PB; Petrie T; Liley B; Leachman SA
Genet Med; 2020 Jan; 22(1):26-34. PubMed ID: 31371819
[TBL] [Abstract][Full Text] [Related]
8. Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone.
Taber JM; Aspinwall LG; Stump TK; Kohlmann W; Champine M; Leachman SA
J Behav Med; 2015 Oct; 38(5):740-53. PubMed ID: 26178773
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families.
Aspinwall LG; Leaf SL; Dola ER; Kohlmann W; Leachman SA
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1510-9. PubMed ID: 18559569
[TBL] [Abstract][Full Text] [Related]
10. Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors.
Glanz K; Volpicelli K; Kanetsky PA; Ming ME; Schuchter LM; Jepson C; Domchek SM; Armstrong K
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):607-14. PubMed ID: 23392000
[TBL] [Abstract][Full Text] [Related]
11. Interactive Beliefs about Genes and Behavior Predict Improved Sun Protection Following Melanoma Genetic Counseling.
Aspinwall LG; Drummond DM; Stump TK; Kohlmann WK; Leachman SA
Ann Behav Med; 2022 Aug; 56(8):816-829. PubMed ID: 35179177
[TBL] [Abstract][Full Text] [Related]
12. Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later.
Aspinwall LG; Taber JM; Leaf SL; Kohlmann W; Leachman SA
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1687-97. PubMed ID: 23950214
[TBL] [Abstract][Full Text] [Related]
13. Impact of melanoma genetic test reporting on perceived control over melanoma prevention.
Aspinwall LG; Stump TK; Taber JM; Kohlmann W; Leaf SL; Leachman SA
J Behav Med; 2015 Oct; 38(5):754-65. PubMed ID: 25822116
[TBL] [Abstract][Full Text] [Related]
14. Family members' perceptions of genetic testing for malignant melanoma--a prospective interview study.
Bergenmar M; Hansson J; Brandberg Y
Eur J Oncol Nurs; 2009 Apr; 13(2):74-80. PubMed ID: 19179113
[TBL] [Abstract][Full Text] [Related]
15. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
Itin PH; Fistarol SK
Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
[TBL] [Abstract][Full Text] [Related]
16. Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.
Levin T; Mæhle L
Fam Cancer; 2017 Apr; 16(2):257-265. PubMed ID: 27804060
[TBL] [Abstract][Full Text] [Related]
17. Sun protection practices among offspring of women with personal or family history of skin cancer.
Geller AC; Brooks DR; Colditz GA; Koh HK; Frazier AL
Pediatrics; 2006 Apr; 117(4):e688-94. PubMed ID: 16585282
[TBL] [Abstract][Full Text] [Related]
18. Parent and child perspectives on family interactions related to melanoma risk and prevention after CDKN2A/p16 testing of minor children.
Wu YP; Aspinwall LG; Parsons B; Stump TK; Nottingham K; Kohlmann W; Champine M; Cassidy P; Leachman SA
J Community Genet; 2020 Jul; 11(3):321-329. PubMed ID: 31955387
[TBL] [Abstract][Full Text] [Related]
19. A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
Smit AK; Espinoza D; Newson AJ; Morton RL; Fenton G; Freeman L; Dunlop K; Butow PN; Law MH; Kimlin MG; Keogh LA; Dobbinson SJ; Kirk J; Kanetsky PA; Mann GJ; Cust AE
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):212-221. PubMed ID: 27702805
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
